Katrin Greimel

Title: Katrin Greimel: Innovator in Abuse-Deterrent Pharmaceutical Compositions

Introduction

Katrin Greimel is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in developing abuse-deterrent compositions. With a total of two patents to her name, her work addresses critical issues related to drug abuse and safety.

Latest Patents

Katrin's latest patents include innovative pharmaceutical compositions designed to deter abuse. The first patent, titled "Abuse-deterrent pharmaceutical composition," discloses a composition that comprises a drug with an enzyme-reactive functional group. This drug has an abuse potential and is paired with an enzyme capable of reacting with the functional group, ensuring that the drug remains in a stable, enzyme-reactive state without enzymatic activity acting on it. The second patent, "Abuse-deterrent pharmaceutical compositions," focuses on compositions that include oxycodone and an oxycodone-processing enzyme. In this formulation, oxycodone is also maintained in a stable, enzyme-reactive state, preventing any enzymatic activity from affecting it.

Career Highlights

Katrin Greimel is currently associated with G.L. Pharma GmbH, where she continues to innovate in the pharmaceutical sector. Her work is pivotal in addressing the challenges posed by drug abuse, making her a key figure in the industry.

Collaborations

Throughout her career, Katrin has collaborated with notable colleagues, including Georg Guebitz and Martin Brandauer. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Katrin Greimel's contributions to the field of pharmaceuticals, particularly in developing abuse-deterrent compositions, highlight her innovative spirit and commitment to improving drug safety. Her work is essential in the ongoing battle against drug abuse, and her patents reflect her dedication to this critical issue.